References
Webb TN, Ramratnam M, Evans RW, Orchard T, Pacella J, Erkan E (2014) Atherosclerotic renal artery stenosis as a cause for hypertension in an adolescent patient. Pediatr Nephrol. doi:10.1007/s00467-00014-02774-y
Tsubakio-Yamamoto K, Nishida M, Nakagawa-Toyama Y, Masuda D, Ohama T, Yamashita S (2010) Current therapy for patients with sitosterolemia–effect of ezetimibe on plant sterol metabolism. J Atheroscler Thromb 17:891–900
Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR Jr, Couture P (2011) Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J Lipid Res 52:558–565
Conflict of interest
Brian Tomlinson has received research funding paid to his institution from Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Merck Serono, Merck Sharp and Dohme, Novartis, Roche, and Takeda. He has also acted as consultant, advisor or speaker for Amgen, AstraZeneca, Genzyme, Janssen, Merck Serono, Merck Sharp and Dohme, Ranbaxy, and Servier.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, M., Tomlinson, B. Ezetimibe treatment should be considered for patients with sitosterolemia. Pediatr Nephrol 29, 1469–1470 (2014). https://doi.org/10.1007/s00467-014-2843-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-014-2843-2